Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
Many people are concerned about the state of their immunity and strive to support it. However, when asking how to strengthen the immune system, not everyone understands where this «immunity» is located or what it consists of. So, here’s a quick overview.
Subscribe to mailing and get the latest news and discounts of our store.>
New edition «Clinical studies of peptide bioregulators»
Dear partners and friends!
We are glad to present to you our new brochure "Reports on the results of clinical studies of peptide bioregulators of the CYTOMAX and CYTOGEN classes".
It contains all the results of many years of research on Peptides bioregulators, which were conducted on the basis of the Institute of Bioregulation and Gerontology, under the direction of V.K. Khavinson.
Now you can easily find all the information about the practical use of bioregulators of the CYTOMAX class - 21 products and CYTOGENES - 6 products, as well as information about the peptides contained in them and recommendations for use.
The new e-brochure from Peptides is a convenient and useful tool for business development. Download new brochure
Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
We are pleased to invite you to explore a new article from the Scientific Information Center on male health and peptide bioregulators — Application of peptide bioregulators to maintain the function of the male reproductive system.
In a recently conducted scientific study within the framework of the SIC project «Clinical and experimental studies of the efficacy of vascular peptides», an in-depth review of the primary aspects of the aforementioned topic will be conducted. The aspects addressed include:
